Loading organizations...
§ Private Profile · Fort Lauderdale, FL, USA
Innovative solutions for early detection and intervention of oral cancer.
Vigilant Biosciences has raised $12.8M across 3 funding rounds.
Vigilant Biosciences has raised $12.8M in total across 3 funding rounds.
Vigilant Biosciences has raised $12.8M across 3 funding rounds. Most recently, it raised $5.0M Series B in July 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 11, 2016 | $5M Series B | — | Venvelo, White OWL Capital Partners | Announced |
| Feb 24, 2015 | $5.5M Series B | — | Venvelo, White OWL Capital Partners | Announced |
| Mar 25, 2014 | $2.3M Debt Financing | — | — | Announced |
Vigilant Biosciences has raised $12.8M in total across 3 funding rounds.
Vigilant Biosciences's investors include venVelo, White Owl Capital Partners.